Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pharmacy and Science

• Publication date

  2005-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.20347PMID 16052543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Challenges in the development of high protein concentration formulations.

  2004cited by this paper
• The effect of volume occupancy upon the thermodynamic activity of proteins: some biochemical consequences

  2004cited by this paper
• The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient

  2003cited by this paper
• Monoclonal antibody therapy for lymphoma.

  2003cited by this paper
• Rituximab (Rituxan®/MabThera®): the first decade (1993–2003)

  2003cited by this paper
• Immunotherapy: new options in breast cancer treatment

  2003cited by this paper
• The utility of monoclonal antibody therapy in renal transplantation.

  2002cited by this paper
• Antibody-directed therapy: past, present, and future.

  2001cited by this paper
• Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

  2000cited by this paper
• Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects.

  1999cited by this paper
• Quantitative characterization of macromolecular associations in solution via real-time and postcentrifugation measurements of sedimentation equilibrium: a comparison.

  1994cited by this paper
• Rapid and accurate microfractionation of the contents of small centrifuge tubes: application in the measurement of molecular weight of proteins via sedimentation equilibrium.

  1993cited by this paper
• Macromolecular crowding: biochemical, biophysical, and physiological consequences.

  1993cited by this paper
• Analytical centrifugation with preparative ultracentrifuges.

  1989cited by this paper
• Sedimentation equilibrium in macromolecular solutions of arbitrary concentration. II. Two protein components

  1987cited by this paper
• Sedimentation equilibrium in macromolecular solutions of arbitrary concentration. I. Self‐associating proteins

  1987cited by this paper
• Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering matchpoints and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences.

  1986cited by this paper
• Specific Volumes of Biological Macromolecules and Some Other Molecules of Biological Interest

  1986cited by this paper
• Protein volumes and hydration effects

  1986cited by this paper
• Proteins: Structures and Molecular Properties

  1986cited by this paper
• Conformation of human IgG subclasses in solution. Small-angle X-ray scattering and hydrodynamic studies.

  1985cited by this paper
• The stabilization of proteins by osmolytes.

  1985cited by this paper
• Size, shape, and hydration of a self-associating human IgG myeloma protein: axial asymmetry as a contributing factor in serum hyperviscosity.

  1984cited by this paper
• Reversible self-association of a human myeloma protein. Thermodynamics and relevance to viscosity effects and solubility.

  1984cited by this paper
• Stabilization of protein structure by sugars.

  1982cited by this paper
• Techniques for the study of biological structure and function

  1980cited by this paper
• Hard quasispherical model for the viscosity of hemoglobin solutions.

  1977cited by this paper
• Rheumatoid arthritis associated with hyperviscosity syndrome and intermediate complex formation.

  1975cited by this paper
• Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein.

  1973cited by this paper
• Equilibrium centrifugation of nonideal systems. Molecular weight moments for removing the effects of nonideality.

  1972cited by this paper
• Equilibrium centrifugation of nonideal systems. The Donnan effect in self-associating systems.

  1971cited by this paper
• Optical methods for measuring nucleoprotein and nucleic acid concentrations.

  1957cited by this paper
• VISCOSITY AND THE SHAPE OF PROTEIN MOLECULES.

  1940cited by this paper

• Effects of Arginine on Hierarchical Protein Aggregation.

  2026cites this paper
• High concentration subcutaneous biological drug products: challenges and advancements.

  2026cites this paper
• Multiscale Diffusion, Dynamic Cluster Formation, and Intermolecular Interactions in Pharmaceutically Relevant Monoclonal Antibody Formulations.

  2025cites this paper
• Enhancing the Protein Stability of an Anticancer VHH‐Fc Heavy Chain Antibody through Computational Modeling and Variant Design

  2025cites this paper
• Analysis of mRNA multimerisation (aggregation) using non-denaturing ion-pair reversed-phase liquid chromatography.

  2025cites this paper
• Diffusion, search and attack motions of antibodies

  2025cites this paper
• Molecular origins of high viscosity in concentrated solutions of monoclonal antibodies.

  2025cites this paper
• Surface Charge and Solvent Exposure Dictate the pH-Dependent Viscosity of Therapeutic Antibodies.

  2025cites this paper
• Temperature and Excipient Mediated Modulation of Monoclonal Antibody Interactions Revealed by kD, Rheology, and Raman Spectroscopy

  2025cites this paper
• Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions

  2025cites this paper
• Electrostatics and viscosity are strongly linked in concentrated antibody solutions.

  2025cites this paper
• Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeutics

  2025influential citation
• Rule-based mitigation of charge asymmetry-triggered monoclonal antibody self-assembly

  2025cites this paper
• Slow and fluctuating dynamics in high concentration BSA protein solutions.

  2025cites this paper
• Dissecting the molecular origins of opalescence and phase separation in mAb formulations and their relation to aggregation

  2025cites this paper
• Monoclonal Antibodies Aggregation during Administration to Patients and the Role of Pharmaceutical Excipients

  2025cites this paper
• AB‐Panda: An AI‐Generated Antibody Structure‐Based Tool for Developability Prediction

  2025cites this paper
• Fast and Scalable Separation of Antibody Aggregates Using Cuboid Size Exclusion Chromatography

  2025cites this paper
• A new shear fluid-assisted multipole yoke method for magnetorheological polishing of SiC materials

  2025cites this paper
• Isoelectric point, net charge and amino acid analysis of experimentally validated therapeutic antibodies.

  2025cites this paper
• Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics.

  2025cites this paper
• Portable Microfluidic Viscometer for Formulation Development and in Situ Quality Control of Protein and Antibody Solutions

  2024cites this paper
• Flow Activation Energy of High-Concentration Monoclonal Antibody Solutions and Protein-Protein Interactions Influenced by NaCl and Sucrose.

  2024cites this paper
• Prediction of Self-Association and Solution Behavior of Monoclonal Antibodies Using the QCM-D Metric of Loosely Interacting Layer

  2024cites this paper
• In-situ biophysical characterization of high-concentration protein formulations using wNMR

  2024cites this paper
• Investigation on environmental factors contributing to bispecific antibody stability and the reversal of self-associated aggregates

  2024cites this paper
• ProtT5 and random forests-based viscosity prediction method for therapeutic mAbs.

  2024cites this paper
• Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody

  2024cites this paper
• The viscoelasticity of high concentration monoclonal antibodies using particle tracking microrheology

  2024cites this paper
• A scaling relationship between thermodynamic and hydrodynamic interactions in protein solutions.

  2024cites this paper
• Elucidation of the Reversible Self-Association Interface of a Diabody-Interleukin Fusion Protein Using Hydrogen-Exchange Mass Spectrometry and In Silico Modeling.

  2024cites this paper
• Stability of Protein Pharmaceuticals: Recent Advances

  2024cites this paper
• Concentration-Dependent Diffusion of Monoclonal Antibodies: Underlying Mechanisms of Anomalous Diffusion.

  2024cites this paper
• A Review of Tangential Flow Filtration: Process Development and Applications in the Pharmaceutical Industry

  2023cites this paper
• Combined Liquid-State and Solid-State Nuclear Magnetic Resonance at Natural Abundance for Comparative Higher Order Structure Assessment in the Formulated-State of Biphasic Biopharmaceutics.

  2023cites this paper
• A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations

  2023cites this paper
• Discovery and Characterization of an Acid-Labile Serine-Lysine Cross-Link in Antibody High-Molecular-Weight Species Using a Multipronged Mass Spectrometry Approach

  2023cites this paper
• Droplet-based microfluidic platform for viscosity measurement over extended concentration range.

  2023cites this paper
• Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions.

  2023cites this paper
• Blueprint for antibody biologics developability

  2023cites this paper
• Prediction of Antibody Viscosity from Dilute Solution Measurements

  2023cites this paper
• Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling

  2023cites this paper
• APPLICATION OF FORMULATION PRINCIPLES TO STABILITY ISSUES ENCOUNTERED DURING PROCESSING, MANUFACTURING, AND STORAGE OF DRUG SUBSTANCE AND DRUG PRODUCT PROTEIN THERAPEUTICS.

  2023cites this paper
• Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations

  2023cites this paper
• Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume

  2023cites this paper
• Deciphering the high viscosity of a therapeutic monoclonal antibody in high concentration formulations by microdialysis-hydrogen/deuterium exchange mass spectrometry.

  2022cites this paper
• Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics

  2022cites this paper
• Characterizing Soluble Protein Aggregates Using Native Mass Spectrometry Coupled with Temperature-Controlled Electrospray Ionization and Size-Excl usion Chromatography.

  2022cites this paper
• Using Cluster Theory to Calculate the Experimental Structure Factors of Antibody Solutions

  2022cites this paper
• Reduction of therapeutic antibody self-association using yeast-display selections and machine learning

  2022cites this paper
• Synergistic Effects of Multiple Excipients on Controlling Viscosity of Concentrated Protein Dispersions.

  2022cites this paper
• Non-specificity as the sticky problem in therapeutic antibody development

  2022cites this paper
• Nanoplasmonic Avidity-Based Detection and Quantification of IgG Aggregates

  2022cites this paper
• A Novel MATLAB®-Algorithm-Based Video Analysis to Quantitatively Determine Solution Creeping in Intact Pharmaceutical Glass Vials.

  2022cites this paper
• Mixed-dimensional multi-scale poroelastic modeling of adipose tissue for subcutaneous injection

  2022cites this paper
• Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.

  2022cites this paper
• Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection.

  2022cites this paper
• Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins

  2022cites this paper
• Application of a Simple Short-Range Attraction and Long-Range Repulsion Colloidal Model toward Predicting the Viscosity of Protein Solutions.

  2022cites this paper
• Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies

  2022cites this paper
• Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties.

  2022cites this paper
• Biophysical characterization and stability of modified IgG1 antibodies with different hexamerization propensities.

  2022cites this paper
• Measuring the Radius of Gyration and Intrinsic Flexibility of Viral Proteins in Buffer Solution Using Small-Angle X-ray Scattering

  2022cites this paper
• Opalescence Arising from Network Assembly in Antibody Solution.

  2022cites this paper
• Positive response to surfactants on the interfacial behavior and aggregation stability of Fab fragments from yolk immunoglobulin.

  2021cites this paper
• Droplet-Based Microfluidic Tool to Quantify Viscosity of Concentrating Protein Solutions

  2021cites this paper
• Nanoencapsulation as a General Solution for Lyophilization of Labile Substrates

  2021cites this paper
• Separation techniques for characterization and quantification of monoclonal antibody purity

  2021cites this paper
• Small-volume extensional rheology of concentrated protein and protein-excipient solutions.

  2021cites this paper
• Towards an improved prediction of concentrated antibody solution viscosity using the Huggins coefficient.

  2021cites this paper
• Lowering the viscosity of a high-concentration antibody solution by protein-polyelectrolyte complex.

  2021cites this paper
• Modelling and optimization of single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies

  2021cites this paper
• Modified Bundle of Capillaries Approximation of Sterilizing Filter Membranes and its Use for Filter Characterization and Filtration Process Optimization.

  2021cites this paper
• A microfluidic approach to studying the injection flow of concentrated albumin solutions

  2021cites this paper
• Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.

  2021cites this paper
• Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions.

  2021cites this paper
• Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods

  2021cites this paper
• Dilute solution viscometry of polymers

  2021cites this paper
• A Review of Formulations of Commercially Available Antibodies.

  2021cites this paper
• Aquafaba, a new plant-based rheological additive for food applications

  2021cites this paper
• Characterization of polymers by LenS3 multiangle light scattering

  2021cites this paper
• Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies

  2021cites this paper
• Stability testing in monoclonal antibodies

  2021cites this paper
• A multi-method approach to assess the self-interaction behavior of Infliximab.

  2021cites this paper
• Comparison of Huggins Coefficients and Osmotic Second Virial Coefficients of Buffered Solutions of Monoclonal Antibodies

  2021cites this paper
• Protein intrinsic viscosity determination with the Viscosizer TD instrument: reaching beyond the initially expected applications

  2021cites this paper
• Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction

  2021cites this paper
• Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

  2021influential citation
• Analysis of nonideality: insights from high concentration simulations of sedimentation velocity data

  2020cites this paper
• Toward Biotherapeutics Formulation Composition Engineering using Site-Identification by Ligand Competitive Saturation (SILCS).

  2020cites this paper
• Prediction Machines: Applied Machine Learning for Therapeutic Protein Design and Development.

  2020cites this paper
• Employing Flow Cytometry to Extracellular Vesicles Sample Microvolume Analysis and Quality Control

  2020cites this paper
• Generation of mAb Variants with Less Attractive Self-Interaction but Preserved Target Binding by Well-Directed Mutation.

  2020cites this paper
• Mitigation of liquid–liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface

  2020cites this paper
• Physicochemical stability of monoclonal antibodies: a review.

  2020cites this paper
• Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy.

  2020cites this paper
• Displacement to separate host‐cell proteins and aggregates in cation‐exchange chromatography of monoclonal antibodies

  2020cites this paper
• Characterization of native reversible self-association of a monoclonal antibody mediated by Fab-Fab interaction.

  2020cites this paper
• Toward Drug-Like Multispecific Antibodies by Design

  2020cites this paper
• Determination of the plastic viscosity of superplasticized cement pastes through capillary viscometers

  2020cites this paper